Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study

Background. Prognosis of therapy results of patients with the juvenile idiopatic arthritis (JIA) without systematic manifestations is the precondition of their treatment efficiency enhancement.Objective. Our aim was to establish early predictors for remission achievement in patients with JIA without...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Вопросы современной педиатрии
المؤلفون الرئيسيون:	Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Dariya D. Vankova, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	"Paediatrician" Publishers LLC 2019-04-01
الموضوعات:	children juvenile idiopatic arthritis therapy predictors risk factors genetically engineered biologic drugs etanercept adverse effects
الوصول للمادة أونلاين:	https://vsp.spr-journal.ru/jour/article/view/2023